Managing menopausal symptoms

Australian Prescriber

Volumn 33, Issue 6, 2010, Pages 171-175

  Foran, Terri ^a,b  

^a Taylor Square Private Clinic ^*  (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bioidentical hormones; Hot flushes; Libido; Urogenital symptoms

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; CONJUGATED ESTROGEN; DYDROGESTERONE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; GABAPENTIN; GESTAGEN; GINKGO BILOBA EXTRACT; LEVONORGESTREL; LUBRICATING AGENT; MEDROXYPROGESTERONE; NORETHISTERONE; NORETHISTERONE ACETATE; PAROXETINE; PLACEBO; PREGABALIN; PROGESTERONE; RED CLOVER EXTRACT; TESTOSTERONE; TIBOLONE; VENLAFAXINE; VITEX AGNUS CASTUS EXTRACT;

ARTICLE; BREAST CANCER; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; FORMICATION; GASTROINTESTINAL SYMPTOM; HORMONAL THERAPY; HOT FLUSH; HUMAN; LIBIDO; LIBIDO DISORDER; LIFESTYLE MODIFICATION; LIVER FAILURE; LOW DRUG DOSE; MENOPAUSAL SYNDROME; NIGHT SWEAT; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE; VASOMOTOR DISORDER;

EID: 78650155939     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2010.082     Document Type: Article

References (28)

1. Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 2009;16:453-7.
2. Greendale G, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005;118(Suppl 12B):148-54.
3. Lethaby AE, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database of Systematic Reviews 2007, Issue 4.
4. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.
5. Baber RJ, Templeman C, Morton T, Kelly G, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.
6. Geller SE, Studee L. Contemporary alternatives to plant estrogens for menopause. Maturitas 2006;55(Suppl 1):S3-13.
7. ADRAC. Hepatotoxicity with black cohosh. Aust Adv Drug React Bull 2006;25:6.
8. Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews 2004, Issue 4.
9. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
10. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 2006;15:35-44.
11. Salpeter SR, Walsh JM, Greyber E, Salpeter EE. Brief report. Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med 2006;21:363-6.
12. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77.
13. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in post menopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
14. Birkhauser MH, Panay N, Archer DF, Barlow D, Burger H, Gambacciani M, et al. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008;11:108-23.
15. Wren BG, Champion SM, Willets K, Manga RZ, Eden JA. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for menopausal women. Menopause 2003;10:13-8.
16. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059-63.
17. Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005;23:6919-30.
18. Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 2010;340:c693.
19. Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flushes: a randomized controlled trial. Menopause 2008;15:310-8.
20. The Jean Hailes Foundation for women's health. 'Bio-identical' Hormones [fact sheet]. Updated 2009 Dec. www.jeanhailes.org.au/images/stories/Education/Documents/ info/bioidentical_hormones.pdf [cited 2010 Nov 16]
21. Eden JA, Hacker NF, Fortune M. Three cases of endometrial cancer associated with 'bioidentical' hormone replacement therapy. Med J Aust 2007;187:244-5.
22. Rymer J, Morris EP. Extracts from 'Clinical evidence': Menopausal symptoms. BMJ 2000;321:1516-9.
23. Notelovitz M. Urogenital aging: solutions in clinical practice. Int J Gynecol Obstet 1997;59(Suppl 1):S35-9.
24. Van der Laak JA, De Bie LM, de Leeuw H, de Wilde PC, Hanselaar AG. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol 2002;55:446-51.
25. Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Whallen K, Notelovitz M. The effects of menopausal hormone therapies on female sexual functioning: review of double-blind randomized controlled trials. Menopause 2004;11:749-65.
26. Tax L, Goorissen EM, Kicovic PM. Clinical profile of Org OD 14. Maturitas 1987:Suppl 1:3-13.
27. Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martínez de Osaba MJ, Casals E, et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000;34:161-8.
28. Egarter C, Huber J, Leikermoser R, Haidbauer R, Pusch H, Fischl F, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996;23:55-62.